Pulmonary ICAM-1 expression has been shown to contribute to IC-induced ALI as treatment with anti-ICAM-1 antibody reduced vascular permeability by 48% and reduced neutrophil recruitment by 40% as measured by MPO buildup in the lungs [31, 32]. This evidence concerns the gene ICAM1 and acute respiratory distress syndrome.